Cue Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	69	119	101	359	379	365	95
Market Cap Growth	-	18.12%	-71.93%	-5.17%	3.77%	285.76%	-
Enterprise Value	32	82	41	302	298	309	54
PE Ratio	-2.35	-2.35	-1.90	-8.13	-8.46	-9.95	-2.43
PS Ratio	12.49	21.70	81.00	24.04	120.08	105.55	82.82
PB Ratio	1.85	3.21	1.54	5.49	4.80	6.69	2.79
P/FCF Ratio	-2.98	-2.98	-2.40	-9.04	-11.45	-11.88	-3.35
P/OCF Ratio	-2.98	-2.98	-2.41	-9.25	-11.66	-11.85	-3.58
EV/Sales Ratio	5.82	15.02	32.62	20.21	94.58	89.26	47.57
EV/EBITDA Ratio	-1.79	-1.79	-0.80	-7.12	-6.85	-8.70	-1.45
EV/EBIT Ratio	-1.67	-1.67	-0.78	-6.92	-6.69	-8.51	-1.42
EV/FCF Ratio	-2.06	-2.06	-0.97	-7.60	-9.02	-10.05	-1.92
Debt / Equity Ratio	0.40	0.40	0.29	0.15	0.09	0.11	-
Debt / EBITDA Ratio	-0.32	-0.32	-0.38	-0.24	-0.16	-0.16	-
Debt / FCF Ratio	-0.37	-0.37	-0.46	-0.25	-0.22	-0.19	-
Quick Ratio	3.11	3.11	6.89	5.50	5.46	5.40	6.48
Current Ratio	3.01	3.01	6.68	5.35	5.37	5.24	6.53
Asset Turnover	0.08	0.08	0.02	0.18	0.03	0.07	0.02
Interest Coverage	-39.75	-39.75	-73.35	-	-	-	-
Return on Equity (ROE)	-112.30%	-112.30%	-88.00%	-65.00%	-61.40%	-115.90%	-87.70%
Return on Assets (ROA)	-71.10%	-71.10%	-61.80%	-51.90%	-48.70%	-72.00%	-77.00%
Return on Capital (ROIC)	-100.41%	-100.41%	-62.95%	-57.86%	-52.34%	-60.90%	-113.91%
Earnings Yield	-73.97%	-42.59%	-52.56%	-12.29%	-11.82%	-10.05%	-41.19%
FCF Yield	-58.26%	-33.54%	-41.62%	-11.06%	-8.74%	-8.41%	-29.87%
Buyback Yield / Dilution	-28.35%	-28.35%	-13.95%	-9.05%	-30.16%	-9.48%	-87.60%
Total Shareholder Return	-28.35%	-28.35%	-13.95%	-9.05%	-30.16%	-9.48%	-87.60%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).